Mass Tort brief
Geopolitical Bias Moves Teva as Israeli Class Actions Expand
Teva scrubs its Israeli origin from a US trial while Israeli courts approve major suits over food labeling and health fund subsidies.
Mass Tort
Geopolitical friction is spilling into corporate law — leading Teva to scrub its Israeli identity to protect against jury bias in U.S. courtrooms.
BackgroundTeva faces major multidistrict litigation in the U.S. over allegations of industry-wide generic price inflation. The company is Israel's largest pharmaceutical producer and a major listing on TASE and NYSE.
- Teva petitioned the Philadelphia court to bar references to its nationality, arguing that geopolitical conflict headlines could unfairly influence American jurors.
- The agreement restricts plaintiffs from raising corporate origin, keeping the upcoming federal trial focused strictly on core antitrust and price-fixing claims.
- The ruling highlights how international conflict headlines create novel litigation risks for foreign corporations defending complex class actions in U.S. courts.
Mass Tort
Misleading sugar labels are opening food chains to massive liability — approving a landmark ₪350 million class action against Golda.
BackgroundIsraeli consumer protection regulations strictly limit sugar-free labels to under 0.5g of sugar per 100g. Golda argued consumers understood the label referred only to added sucrose.
- Lab analysis showed Golda's sugar-free coffee and hazelnut gelatos contained 6.6g of sugar per 100g, far exceeding regulatory limits.
- The court rejected Golda's defense, allowing claims for full consumer refunds spanning seven years of nationwide product sales.
- The certified suit represents one of the largest food labeling class actions approved in Israeli legal history, setting a precedent for dairy product marketing.
Mass Tort
Labor courts are striking down targeted health insurance discounts — enforcing statutory non-discrimination rules across Israeli HMOs.
BackgroundIsraeli National Health Insurance Law prohibits health funds from adjusting supplementary insurance rates based on family size or income. Large family discounts disproportionately benefit Haredi households over non-Haredi families.
- Judge Ofira Dagan-Tochmacher ruled that discounting fourth-child coverage violates statutory equality requirements governing statutory healthcare providers.
- HMOs including Clalit and Maccabi must review the legal grounding of their family subsidy structures, risking millions in premium restitution.
- The legal challenge threatens to eliminate long-standing family discounts used by health funds as a primary marketing tool to recruit large households.
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
